PhD in Targeted Peptide Multi-Agonist Drugs

Pre-clinical development of targeted peptide multi-agonist drugs for improved diabetes and obesity management/n/nSummary. Type 2 diabetes mellitus is often associated with obesity, as well as reduced insulin secretion and impaired insulin action, which leads to disease complications through persistent hyperglycaemia./n/nDepartment: Faculty of Life and Health Sciences/nProgram type: PhD Research Project/nUpdated date: 15 December 2025